rabbit anti nrxn1 polyclonal antibody  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Name:
    Anti Neurexin 1alpha extracellular Antibody
    Description:
    Anti Neurexin 1α extracellular Antibody ANR 031 is a highly specific antibody directed against an epitope of the rat protein The antibody can be used in western blot and live cell imaging applications The antibody recognizes an extracellular epitope and is therefore highly suited to recognize neurexin 1α in living cells It has been designed to recognize Nrxn1α from rat mouse and human samples
    Catalog Number:
    ANR-031
    Price:
    397.0
    Category:
    Primary Antibody
    Applications:
    Immunocytochemistry, Immunofluorescence, Live Cell Imaging, Western Blot
    Purity:
    Affinity purified on immobilized antigen.
    Immunogen:
    Synthetic peptide
    Size:
    25 mcl
    Antibody Type:
    Polyclonal Primary Antibodies
    Format:
    Lyophilized Powder
    Host:
    Rabbit
    Isotype:
    Rabbit IgG
    Buy from Supplier


    Structured Review

    Alomone Labs rabbit anti nrxn1 polyclonal antibody
    Anti Neurexin 1alpha extracellular Antibody
    Anti Neurexin 1α extracellular Antibody ANR 031 is a highly specific antibody directed against an epitope of the rat protein The antibody can be used in western blot and live cell imaging applications The antibody recognizes an extracellular epitope and is therefore highly suited to recognize neurexin 1α in living cells It has been designed to recognize Nrxn1α from rat mouse and human samples
    https://www.bioz.com/result/rabbit anti nrxn1 polyclonal antibody/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti nrxn1 polyclonal antibody - by Bioz Stars, 2021-09
    93/100 stars

    Images

    1) Product Images from "NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer"

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

    Journal: Oncotarget

    doi: 10.18632/oncotarget.27718

    NRXN1 expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.
    Figure Legend Snippet: NRXN1 expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.

    Techniques Used: Expressing, Quantitative RT-PCR, SYBR Green Assay

    NRXN1 expression in cell lines and surgical specimens of lung tissue including non-SCLC and normal tissues. ( A ) The relative expressions in cell lines were examined using qRT-PCR with the SYBR green dye assay; data for NRXN1 is shown. The log 2 -scale relative gene expression is indicated on the y -axis. Error bars, SD. ( B ) Flow cytometry of NRXN1 on cell lines. Cell surface NRXN1 was assessed using FITC-conjugated anti-rabbit polyclonal antibody following rabbit anti-NRXN1 (Black trace) or IgG isotype control (gray-filled) antibodies. FCM, flow cytometry. ( C ) Percentage of NRXN1-positive cells examined for each cell line using flow cytometry. Cells were stained with rabbit anti-NRXN1 polyclonal antibody followed by FITC conjugated goat anti-rabbit IgG. A one-way analysis of variance (ANOVA) followed by the Tukey test was performed. ( * P
    Figure Legend Snippet: NRXN1 expression in cell lines and surgical specimens of lung tissue including non-SCLC and normal tissues. ( A ) The relative expressions in cell lines were examined using qRT-PCR with the SYBR green dye assay; data for NRXN1 is shown. The log 2 -scale relative gene expression is indicated on the y -axis. Error bars, SD. ( B ) Flow cytometry of NRXN1 on cell lines. Cell surface NRXN1 was assessed using FITC-conjugated anti-rabbit polyclonal antibody following rabbit anti-NRXN1 (Black trace) or IgG isotype control (gray-filled) antibodies. FCM, flow cytometry. ( C ) Percentage of NRXN1-positive cells examined for each cell line using flow cytometry. Cells were stained with rabbit anti-NRXN1 polyclonal antibody followed by FITC conjugated goat anti-rabbit IgG. A one-way analysis of variance (ANOVA) followed by the Tukey test was performed. ( * P

    Techniques Used: Expressing, Quantitative RT-PCR, SYBR Green Assay, Flow Cytometry, Staining

    In vitro growth inhibition of NRXN1-targeted ADC. ( A – F ) In vitro growth inhibition of anti-NRXN1 monoclonal antibody only, secondary ADC only, isotype control antibody (IgG) followed by secondary ADC, and anti-NRXN1 monoclonal antibody followed by secondary ADC on incubation with (A) SHP77, (B) SHP77 KO, (C) HEK293, (D) HEK293-NRXN1, (E) NCI-H526, and (F) PDC. All the assays were performed in triplicate. A two-way ANOVA followed by the Tukey test was performed to assess the difference between IgG with the second ADC group and anti-NRXN1 mAb with the second ADC group. A P value
    Figure Legend Snippet: In vitro growth inhibition of NRXN1-targeted ADC. ( A – F ) In vitro growth inhibition of anti-NRXN1 monoclonal antibody only, secondary ADC only, isotype control antibody (IgG) followed by secondary ADC, and anti-NRXN1 monoclonal antibody followed by secondary ADC on incubation with (A) SHP77, (B) SHP77 KO, (C) HEK293, (D) HEK293-NRXN1, (E) NCI-H526, and (F) PDC. All the assays were performed in triplicate. A two-way ANOVA followed by the Tukey test was performed to assess the difference between IgG with the second ADC group and anti-NRXN1 mAb with the second ADC group. A P value

    Techniques Used: In Vitro, Inhibition, Incubation

    Apoptosis assay of NRXN1-targeted ADC at IC 50 dose calculated by growth inhibition curves. Late apoptotic cells were quantified by Cy7-conjugated annexin-V and PI using flow cytometry. Results were analyzed using a one-way ANOVA followed by the Dunnett multiple comparisons test ( * P
    Figure Legend Snippet: Apoptosis assay of NRXN1-targeted ADC at IC 50 dose calculated by growth inhibition curves. Late apoptotic cells were quantified by Cy7-conjugated annexin-V and PI using flow cytometry. Results were analyzed using a one-way ANOVA followed by the Dunnett multiple comparisons test ( * P

    Techniques Used: Apoptosis Assay, Inhibition, Flow Cytometry

    2) Product Images from "NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer"

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

    Journal: Oncotarget

    doi: 10.18632/oncotarget.27718

    NRXN1 expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.
    Figure Legend Snippet: NRXN1 expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.

    Techniques Used: Expressing, Quantitative RT-PCR, SYBR Green Assay

    NRXN1 expression in cell lines and surgical specimens of lung tissue including non-SCLC and normal tissues. ( A ) The relative expressions in cell lines were examined using qRT-PCR with the SYBR green dye assay; data for NRXN1 is shown. The log 2 -scale relative gene expression is indicated on the y -axis. Error bars, SD. ( B ) Flow cytometry of NRXN1 on cell lines. Cell surface NRXN1 was assessed using FITC-conjugated anti-rabbit polyclonal antibody following rabbit anti-NRXN1 (Black trace) or IgG isotype control (gray-filled) antibodies. FCM, flow cytometry. ( C ) Percentage of NRXN1-positive cells examined for each cell line using flow cytometry. Cells were stained with rabbit anti-NRXN1 polyclonal antibody followed by FITC conjugated goat anti-rabbit IgG. A one-way analysis of variance (ANOVA) followed by the Tukey test was performed. ( * P
    Figure Legend Snippet: NRXN1 expression in cell lines and surgical specimens of lung tissue including non-SCLC and normal tissues. ( A ) The relative expressions in cell lines were examined using qRT-PCR with the SYBR green dye assay; data for NRXN1 is shown. The log 2 -scale relative gene expression is indicated on the y -axis. Error bars, SD. ( B ) Flow cytometry of NRXN1 on cell lines. Cell surface NRXN1 was assessed using FITC-conjugated anti-rabbit polyclonal antibody following rabbit anti-NRXN1 (Black trace) or IgG isotype control (gray-filled) antibodies. FCM, flow cytometry. ( C ) Percentage of NRXN1-positive cells examined for each cell line using flow cytometry. Cells were stained with rabbit anti-NRXN1 polyclonal antibody followed by FITC conjugated goat anti-rabbit IgG. A one-way analysis of variance (ANOVA) followed by the Tukey test was performed. ( * P

    Techniques Used: Expressing, Quantitative RT-PCR, SYBR Green Assay, Flow Cytometry, Staining

    In vitro growth inhibition of NRXN1-targeted ADC. ( A – F ) In vitro growth inhibition of anti-NRXN1 monoclonal antibody only, secondary ADC only, isotype control antibody (IgG) followed by secondary ADC, and anti-NRXN1 monoclonal antibody followed by secondary ADC on incubation with (A) SHP77, (B) SHP77 KO, (C) HEK293, (D) HEK293-NRXN1, (E) NCI-H526, and (F) PDC. All the assays were performed in triplicate. A two-way ANOVA followed by the Tukey test was performed to assess the difference between IgG with the second ADC group and anti-NRXN1 mAb with the second ADC group. A P value
    Figure Legend Snippet: In vitro growth inhibition of NRXN1-targeted ADC. ( A – F ) In vitro growth inhibition of anti-NRXN1 monoclonal antibody only, secondary ADC only, isotype control antibody (IgG) followed by secondary ADC, and anti-NRXN1 monoclonal antibody followed by secondary ADC on incubation with (A) SHP77, (B) SHP77 KO, (C) HEK293, (D) HEK293-NRXN1, (E) NCI-H526, and (F) PDC. All the assays were performed in triplicate. A two-way ANOVA followed by the Tukey test was performed to assess the difference between IgG with the second ADC group and anti-NRXN1 mAb with the second ADC group. A P value

    Techniques Used: In Vitro, Inhibition, Incubation

    Apoptosis assay of NRXN1-targeted ADC at IC 50 dose calculated by growth inhibition curves. Late apoptotic cells were quantified by Cy7-conjugated annexin-V and PI using flow cytometry. Results were analyzed using a one-way ANOVA followed by the Dunnett multiple comparisons test ( * P
    Figure Legend Snippet: Apoptosis assay of NRXN1-targeted ADC at IC 50 dose calculated by growth inhibition curves. Late apoptotic cells were quantified by Cy7-conjugated annexin-V and PI using flow cytometry. Results were analyzed using a one-way ANOVA followed by the Dunnett multiple comparisons test ( * P

    Techniques Used: Apoptosis Assay, Inhibition, Flow Cytometry

    Related Articles

    Immunohistochemistry:

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer
    Article Snippet: .. We tested commercially available anti-NRXN1 polyclonal antibodies (ANR-031 from Alomone Labs and ab214191 from Abcam) for immunohistochemistry using SCLC tissue microarrays, but they lacked specificity (data not shown). ..

    Flow Cytometry:

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer
    Article Snippet: .. Flow cytometry Cells were incubated with 2.5 μL of rabbit anti-NRXN1 polyclonal antibody (ANR-031; Alomone Labs) or an isotype control at 1 × 105 cells/100 μL in PBS with 2% FBS for 30 min in the dark. ..

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer
    Article Snippet: .. Anti-NRXN1α polyclonal antibody raised in rabbits (ANR-031; Alomone Labs, Jerusalem, Israel) against amino acid residues 546-560 of rat NRXN1α was applied for NRXN1 measurements using flow cytometry. ..

    Incubation:

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer
    Article Snippet: .. Flow cytometry Cells were incubated with 2.5 μL of rabbit anti-NRXN1 polyclonal antibody (ANR-031; Alomone Labs) or an isotype control at 1 × 105 cells/100 μL in PBS with 2% FBS for 30 min in the dark. ..

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Alomone Labs rabbit anti nrxn1 polyclonal antibody
    <t>NRXN1</t> expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.
    Rabbit Anti Nrxn1 Polyclonal Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti nrxn1 polyclonal antibody/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti nrxn1 polyclonal antibody - by Bioz Stars, 2021-09
    93/100 stars
      Buy from Supplier

    90
    Alomone Labs anti neurexin 1α extracellular atto 488 antibody
    Effect of HSA-28P and HSA-28 on the binding affinity of <t>anti-Neurexin</t> <t>1α</t> antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.
    Anti Neurexin 1α Extracellular Atto 488 Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti neurexin 1α extracellular atto 488 antibody/product/Alomone Labs
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti neurexin 1α extracellular atto 488 antibody - by Bioz Stars, 2021-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    NRXN1 expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.

    Journal: Oncotarget

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

    doi: 10.18632/oncotarget.27718

    Figure Lengend Snippet: NRXN1 expression in normal multiple organs in humans. The relative expressions of NRXN1 in normal multiple organs of human tissue were examined using qRT-PCR with the SYBR green dye assay. The y-axis shows the NRXN1 expression levels relative to normal lung tissue. The y-axis is set to the same scale as that of Figure 1D so that the expression intensities of both surgical specimens and normal organs can be visually compared. Error bars, SD.

    Article Snippet: Flow cytometry Cells were incubated with 2.5 μL of rabbit anti-NRXN1 polyclonal antibody (ANR-031; Alomone Labs) or an isotype control at 1 × 105 cells/100 μL in PBS with 2% FBS for 30 min in the dark.

    Techniques: Expressing, Quantitative RT-PCR, SYBR Green Assay

    NRXN1 expression in cell lines and surgical specimens of lung tissue including non-SCLC and normal tissues. ( A ) The relative expressions in cell lines were examined using qRT-PCR with the SYBR green dye assay; data for NRXN1 is shown. The log 2 -scale relative gene expression is indicated on the y -axis. Error bars, SD. ( B ) Flow cytometry of NRXN1 on cell lines. Cell surface NRXN1 was assessed using FITC-conjugated anti-rabbit polyclonal antibody following rabbit anti-NRXN1 (Black trace) or IgG isotype control (gray-filled) antibodies. FCM, flow cytometry. ( C ) Percentage of NRXN1-positive cells examined for each cell line using flow cytometry. Cells were stained with rabbit anti-NRXN1 polyclonal antibody followed by FITC conjugated goat anti-rabbit IgG. A one-way analysis of variance (ANOVA) followed by the Tukey test was performed. ( * P

    Journal: Oncotarget

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

    doi: 10.18632/oncotarget.27718

    Figure Lengend Snippet: NRXN1 expression in cell lines and surgical specimens of lung tissue including non-SCLC and normal tissues. ( A ) The relative expressions in cell lines were examined using qRT-PCR with the SYBR green dye assay; data for NRXN1 is shown. The log 2 -scale relative gene expression is indicated on the y -axis. Error bars, SD. ( B ) Flow cytometry of NRXN1 on cell lines. Cell surface NRXN1 was assessed using FITC-conjugated anti-rabbit polyclonal antibody following rabbit anti-NRXN1 (Black trace) or IgG isotype control (gray-filled) antibodies. FCM, flow cytometry. ( C ) Percentage of NRXN1-positive cells examined for each cell line using flow cytometry. Cells were stained with rabbit anti-NRXN1 polyclonal antibody followed by FITC conjugated goat anti-rabbit IgG. A one-way analysis of variance (ANOVA) followed by the Tukey test was performed. ( * P

    Article Snippet: Flow cytometry Cells were incubated with 2.5 μL of rabbit anti-NRXN1 polyclonal antibody (ANR-031; Alomone Labs) or an isotype control at 1 × 105 cells/100 μL in PBS with 2% FBS for 30 min in the dark.

    Techniques: Expressing, Quantitative RT-PCR, SYBR Green Assay, Flow Cytometry, Staining

    In vitro growth inhibition of NRXN1-targeted ADC. ( A – F ) In vitro growth inhibition of anti-NRXN1 monoclonal antibody only, secondary ADC only, isotype control antibody (IgG) followed by secondary ADC, and anti-NRXN1 monoclonal antibody followed by secondary ADC on incubation with (A) SHP77, (B) SHP77 KO, (C) HEK293, (D) HEK293-NRXN1, (E) NCI-H526, and (F) PDC. All the assays were performed in triplicate. A two-way ANOVA followed by the Tukey test was performed to assess the difference between IgG with the second ADC group and anti-NRXN1 mAb with the second ADC group. A P value

    Journal: Oncotarget

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

    doi: 10.18632/oncotarget.27718

    Figure Lengend Snippet: In vitro growth inhibition of NRXN1-targeted ADC. ( A – F ) In vitro growth inhibition of anti-NRXN1 monoclonal antibody only, secondary ADC only, isotype control antibody (IgG) followed by secondary ADC, and anti-NRXN1 monoclonal antibody followed by secondary ADC on incubation with (A) SHP77, (B) SHP77 KO, (C) HEK293, (D) HEK293-NRXN1, (E) NCI-H526, and (F) PDC. All the assays were performed in triplicate. A two-way ANOVA followed by the Tukey test was performed to assess the difference between IgG with the second ADC group and anti-NRXN1 mAb with the second ADC group. A P value

    Article Snippet: Flow cytometry Cells were incubated with 2.5 μL of rabbit anti-NRXN1 polyclonal antibody (ANR-031; Alomone Labs) or an isotype control at 1 × 105 cells/100 μL in PBS with 2% FBS for 30 min in the dark.

    Techniques: In Vitro, Inhibition, Incubation

    Apoptosis assay of NRXN1-targeted ADC at IC 50 dose calculated by growth inhibition curves. Late apoptotic cells were quantified by Cy7-conjugated annexin-V and PI using flow cytometry. Results were analyzed using a one-way ANOVA followed by the Dunnett multiple comparisons test ( * P

    Journal: Oncotarget

    Article Title: NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

    doi: 10.18632/oncotarget.27718

    Figure Lengend Snippet: Apoptosis assay of NRXN1-targeted ADC at IC 50 dose calculated by growth inhibition curves. Late apoptotic cells were quantified by Cy7-conjugated annexin-V and PI using flow cytometry. Results were analyzed using a one-way ANOVA followed by the Dunnett multiple comparisons test ( * P

    Article Snippet: Flow cytometry Cells were incubated with 2.5 μL of rabbit anti-NRXN1 polyclonal antibody (ANR-031; Alomone Labs) or an isotype control at 1 × 105 cells/100 μL in PBS with 2% FBS for 30 min in the dark.

    Techniques: Apoptosis Assay, Inhibition, Flow Cytometry

    Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.

    Journal: ACS applied materials & interfaces

    Article Title: Mimicking Neuroligin-2 Functions in β-cells by Functionalized Nanoparticles as a Novel Approach for Antidiabetic Therapy

    doi: 10.1021/acsami.6b10568

    Figure Lengend Snippet: Effect of HSA-28P and HSA-28 on the binding affinity of anti-Neurexin 1α antibody INS-1E cells that were seeded in 12-well plates. The cells were incubated with HSA-28P, “naked” nanoparticles or HSA-28 peptide for 24 h. After the indicated incubation time, cells were exposed to ATTO 488-fluorescent labeled antibody against an extracellular epitope of Neurexin 1α according to the manufacturer`s protocol. After then, cells were taken to Gallios Fluorescence Activated Cell Sorter. Control cells (A), treated only by anti-Neurexin 1α antibody ( B ), treated by HSA-28P and anti-Neurexin 1α antibody ( C ), treated by “naked” nanoparticles and anti-Neurexin 1α antibody ( D ) and finally cells treated by HSA-28 and anti-Neurexin 1α antibody ( E ). The summary of the spectra of the fluorescent signals (F). The summary of cell counts and percentage of the inhibition. n=3.

    Article Snippet: Anti-Neurexin 1α (extracellular)-ATTO-488 antibody was purchased from (Alomone Labs, Jerusalem, Israel) .

    Techniques: Binding Assay, Incubation, Labeling, Fluorescence, Inhibition